Tag Archives: LungImaging

Introduction to Functional Respiratory Imaging (FRI) for Investors and Market Analysts

For those who cannot attend our event coming Thursday at Flanders House in New York, you are welcome to register for the Webcast via following link:

https://attendee.gotowebinar.com/register/8186175617140384514

 

 

 

FLUIDDA is delighted to invite you to a dedicated session discussing her proprietary Functional Respiratory Imaging (FRI) technology and its application in drug and device development.

During the presentation FLUIDDA’s CEO, Dr. Jan De Backer, will present the technology and explain how it can be used to assess the potential of new respiratory drugs and devices. Some recent examples in Idiopathic Pulmonary Fibrosis (IPF) and Chronic Obstructive Pulmonary Disease (COPD) will be highlighted and an update on the regulatory status of FRI will provided.

The primary target audience for the session consists of market analysts and investors, however anyone with an interest in therapeutic development in respiratory medicine is welcome to register.

Kindly register by providing the following information, seating is limited:

Fields marked with an * are required

 

Study confirmed enhanced sensitivity of Functional Respiratory Imaging (FRI) compared to conventional lung function measures in IPF trial

” We were very impressed by the additional insights FRI brought to this clinical trial. The FRI data gave us confidence in the potential of this drug, supporting the signal observed in the lung function measurements. This type of information is very valuable when designing the next clinical trials for this compound.” Dr Piet Wigerinck, Chief… Continue Reading

FRI in IPF-PH paves the way for Phase IIb trial with INOpulse Device

“The U.S. Food and Drug Administration approved the design of a Phase 2b trial of INOpulse, a device that delivers nitric oxide, as a treatment for patients with pulmonary hypertension associated with lung disease. INOpulse’s developer, Bellerophon Therapeutics, said the sign-off came after a meeting with the FDA in June. In addition to the Phase 2b design, the… Continue Reading

ERS 2016: We are ready!

We are ready to show the more than 20,000 respiratory healthcare professionals at ERS 2016 our new Broncholab platform! Broncholab uses FLUIDDA’s FRI technology to bring personalised medicine closer than ever before to patients suffering from terrible lung diseases. Continue Reading

Fluidda NV

Groeningenlei 132

2550 Kontich

Belgium

BE 0877 160 706

Tel: +32/(0)3 450 87 20

Fax: +32/(0)3 450 87 29

info@fluidda.com

Fluidda NV

Groeningenlei 132

2550 Kontich

Belgium

BE 0877 160 706

Tel: +32/(0)3 450 87 20

Fax: +32/(0)3 450 87 29

info@fluidda.com

FLUIDDA, Inc

675 US Highway One
North Brunswick, NJ 08902
United States

FLUIDDA, Inc

675 US Highway One
North Brunswick, NJ 08902
United States

FLUIDDA India

Medical Imaging pvt ltd
A-95/96, DGP Nagar -2, Ambad
Nashik 422010
India

FLUIDDA India

Medical Imaging pvt ltd
A-95/96, DGP Nagar -2, Ambad
Nashik 422010
India

All content © FLUIDDA 2017